Sebocytes, the major cell type in sebaceous glands, are differentiated epithelial cells that gradually accumulate lipids and eventually disrupt, releasing their content (sebum) in a secretory process known as holocrine secretion. Via the hair canal, sebum reaches the skin surface, where it has several known or postulated functions, including pheromonal, thermoregulatory, antimicrobial and antioxidant activities. Altered sebum secretion and/ or structural sebaceous gland changes have also been involved in the pathogenesis of skin diseases, such as acne vulgaris and some forms of alopecia. Here, we assess how recent work employing primary sebocytes and sebaceous gland cell lines contributed for our understanding of sebaceous lipogenesis and its role in skin health and disease.
| INTRODUC TI ON
Sebaceous glands (SGs) are hair follicle-associated exocrine skin glands that continuously release sebum, a mixture of lipids and cell debris, by holocrine secretion. [1] [2] [3] [4] The released sebum reaches the skin surface via the hair canal and forms a putatively protective film over the epidermis and the hair shafts. A plethora of functions have been attributed to sebum, including antimicrobial and antioxidative properties. [5] [6] [7] [8] Interestingly, sebaceous lipids have just been shown to be actively distributed by the SGs in their dermal periphery and to influence the activity of perifollicular macrophages, adding new possible functions to the numerous ones previously reported. [9] Perturbations of SG function are involved in the pathogenesis of various human skin diseases. [8, 10] Thus, increased and/or modified sebum production is a key feature of acne vulgaris, the most frequent skin disorder during adolescence, [11, 12] while SG degeneration is a typical characteristic of psoriatic alopecia [13, 14] and is also found in hidradenitis suppurativa, [15] lichen planopilaris, [16] pseudopelade of Brocq [17] and in some rare forms of cicatricial alopecia, such as primary cicatricial alopecia, [18] linear morphea [19] and Zouboulis syndrome. [20] Some animal models for studying SG biology and disease exist, [21, 22] such as the asebia mouse, a well-studied animal model for primary cicatricial alopecia that develops SG atrophy due to a spontaneous mutation in the gene encoding the enzyme stearoylcoenzyme A desaturase 1. [23] Other examples include the use of rat preputial sebocytes [24] and hamster sebocytes. [25] However, reflecting its different functions in humans compared to other mammals, sebum composition is remarkably species-specific. The main components of the human sebum lipid fraction are triglycerides, diglycerides and free fatty acids (~57.5%), with lower levels of wax esters (~26%), squalene (~12%) and cholesterol (~4.5%). [4] In other species, some components are missing (for instance squalene) or are present in different amounts. [5, 26] In addition to the lipids, there are also significant species-specific differences regarding SG structure (which varies greatly depending on the associated hair follicle type) or sebaceous markers. For instance, keratin 7 and MUC1 are sebaceous markers in human but not in murine SGs. [21] These dissimilarities explain why SG-associated diseases also differ between species, the restriction of acne to human sebaceous follicles being an illustrative example. [27] Thus, although SG studies in rodents will greatly benefit from recent technical advances such as sebocyte-specific gene manipulation, [28] it is essential to study human sebocytes in order to understand SG biology, sebum functions and SG-associated diseases in humans. Here, we focus on previous studies addressing 
| ISOL ATI ON AND CULTURE OF PRIMARY H UMAN S EBO C Y TE S
The advances in the isolation and culture of human SG cells have been reviewed in detail by Zouboulis and colleagues, [29] [30] [31] and the interested reader will find more information in their work and in the references therein. We will present a selection of the key developments in this area in a chronological manner (Figure 1 ). The first detailed report on the isolation, characterization and maintenance of human sebocytes in vitro was presented in 1989: Xia and colleagues isolated SGs by microdissection from human pilosebaceous units (separated from the dermis together with the epidermis by dispase treatment), removed the ducts and seeded the gland lobules on a 3T3 feeder cell layer. [32] After 2-3 weeks, outgrowths derived from the lobules were dispersed and cells preserving sebocytes characteristics could be isolated and passaged 3 times. [32] Doran and colleagues selected a different approach: after discarding the first 0.4-mm section of the skin, the second 0.4-mm section was enzymatically treated to dissociate the cells, which were the further cultured on a 3T3 feeder layer. [33] Fujie and colleagues followed the method described by Xia and al., i.e., mechanically isolated the SGs that remained attached to the epidermis after removal of the dermis, but isolated cells either by explant culture or by SG enzymatic dissociation without using a feeder layer. [34] Interestingly, while both methods resulted in a linear increase in cell number, cessation of growth was observed after passage 3 for the explant method but only after passage 6 for the dispersed cell culture method. [34] Researchers were frequently able to isolate cells with high viability that exhibited the typical morphological characteristics and the differentiation behaviour of sebocytes. These included expression of typical sebocyte markers, such as the epithelial membrane antigen (EMA), and the hallmark of sebocyte differentiation, the ability to accumulate cytoplasmic lipid droplets upon a corresponding stimulus.
The latter aspect included both "unspecific" lipid staining such as Nile red, and more specific determination of typical lipid classes such as squalene, wax esters and free fatty acids by thin-layer chromatography and their comparison to keratinocyte lipids. Indeed, the probably most important quality criterion was to exclude the actual isolation of keratinocytes, for instance by demonstrating the absence of typical keratinocyte markers and by the inability of the cells to produce a cornified envelope. [32] Primary human sebocytes were extremely important for identifying markers and pathways of sebaceous lipogenesis, and as illustrated by 2 recent examples, [35, 36] they are still widely employed for studies addressing the influence of different substances or gene products on sebaceous lipogenesis. Furthermore, primary sebocytes will certainly benefit from future technical developments. For instance, by treating cells with Y-27632, a small molecule that inhibits both isoforms of Rho-associated protein kinase, Nelson and colleagues were able to expand human primary sebocytes in vitro, thus overcoming the need for oncogene-driven immortalization. [37] The authors reported a great variation in the characteristics of the individual cultures, making it essential to carefully characterize each culture before its application in downstream experiments.
Nevertheless, this promising method has the potential to overcome the major limitation of primary sebocytes: the fact that they show slow proliferation (compared to keratinocytes from the same donors) and exhibit a strong tendency to spontaneously differentiate in vitro. [30, 38] These features preclude long-term experiments and the production of a greater number of cells for large-scale experiments.
As we will see below, these problems have been largely overcome by generating immortalized SG cell lines.
| E S TAB LIS HMENT OF IMMORTALIZED H UMAN SG CELL LINE S
The first immortalized human SG cell line, SZ95, was established by Zouboulis and colleagues [39] by isolating facial sebocytes from an 87-year-old woman and transfecting them with the simian virus additional (but so far less employed) immortalized human SG cell lines, Seb-E6E7 [42] and SEBO662, [43] were established by transfecting SG cells with HPV16 E6 and E7 genes. While the presence and the regulation of typical sebaceous lipids were also documented for SEB-1 [41] and SEBO662, [44] other important characteristics such as the expression of growth factors, hormones and cytokines as well as of the corresponding receptors have only been so far characterized in SZ95 sebocytes. [45] However, a systematic comparison between primary sebocytes and the available sebocyte cell lines has not been reported so far.
| S TUDYING SG B I OLOGY AND PATHOLOGY WITH SG CELL LINE S
The available immortalized SG cell lines display a number of characteristics that make them an excellent tool for studying different aspects of the SG functions. However, they also share the drawback that regulated, full sebaceous differentiation including holocrine secretion by cell disruption could not be achieved so far. Nevertheless, as reviewed elsewhere, [6, 7, 29] these cell lines have been an extremely useful tool in different projects across the world addressing topics as diverse as lipogenesis and innate immunity (Table 1) .
Current developments of 3-dimensional culture systems are likely to enhance the applicability and relevance of human SG cell lines in human biology and pathophysiology. When maintained in 3D culture, SZ95 sebocytes formed spheroids that included a basement membrane. [46] These structures, when exposed to prostaglandin E2, became larger and adopted a more complex organization compared to control spheroids by activating the canonical Wnt signalling pathway as well as increasing cell viability and proliferation, mitochondrial metabolism and lipid synthesis. [46] Moreover, a coculture model of explant skin in direct contact with SZ95 sebocytes resulted in overall improved structural integrity of the epidermis, higher percentage of proliferating basal and reduced apoptosis of differentiating epidermal cells, whereas SZ95 sebocytes exhibited morphological and biochemical signs of normal differentiation. [47] These data provided evidence of a beneficial interaction between sebocytes and skin explants, providing the rationale for their integration in 3-dimensional skin models. Finally, when placed at the air-liquid interface, SEBO662
sebocytes formed a multilayered epithelium expressing a number of sebaceous markers and spontaneously exhibiting polarized lipid accumulation at their upper (external) side.
[43]
| CON CLUS IONS
Immortalized human SG cell lines can be easily expanded to allow large-scale studies, are amenable for a number of experiments, and, as they are of human origin, reflect the lipid profile and arguably the receptor configuration of human sebocytes in vivo. The mentioned features make them a particularly handy tool for studying 
Experimental question Cell line References
Antimicrobial role of sebum (innate immunity) SZ95 [58] [59] [60] [61] [62] [63] SEB-1 [64] Expression and regulation of sebocyte lipid droplet-associated proteins SZ95 [50, [65] [66] [67] Seb-E6E7 [50] Mechanisms of IGF-1-mediated stimulation of sebaceous lipogenesis SEB-1 [68, 69] SZ95 [70] Actions of peroxisome proliferator-activated receptors in sebocytes SEB-1 [71] SZ95 [72] [73] [74] Actions of endocannabinoids in sebocytes SZ95 [75] Mechanisms of retinoid-mediated inhibition of sebaceous lipogenesis SZ95 [39, 76] SEB-1 [77] [78] [79] Expression of steroidogenesis-related enzymes and regulation of local androgen synthesis SZ95 [40, 80] SEB-1 [41] SEBO662 [44] Mechanisms of apoptosis in sebocytes SZ95 [81] SEB-1 [41] Cutaneous functions of the vitamin D system SZ95 [82, 83] Regulation of sebaceous lipogenesis by microRNAs SZ95 [49] Neuropeptide synthesis and their action on sebocytes SZ95 [84, 85] molecular and cellular processes underlying sebaceous lipogenesis and their perturbation in SG diseases (Table 1) . Recent examples of fields pushed forward by employing immortalized human SG cell lines include the analysis of sebocyte adipokines, [48] the identification of microRNAs associated with sebaceous differentiation, [49] and the study of the proteins associated with cytoplasmic SG lipid droplets [50] or secreted by sebocytes in addition to the lipid synthesis. [51] Available SG cell lines clearly show limitations as models for sebaceous differentiation, as they only undergo incomplete differentiation and are usually grown under 2-dimensional conditions. Although there have been initial attempts to establish 3-dimensional culture systems, [46, 47] the results are not satisfactory yet. Another major limitation is the restricted possibility to study the interaction of different cell types, such as the formation of SGs during embryonic development and the multifactorial (and multicellular) character of acne pathogenesis. These drawbacks may in part explain why the application of SG cell lines for dermatological drug discovery remains challenging. An important task here is the development of SG "organoids," in vitro 3D
structures resembling the cellular organization of the original gland, an approach that has been successfully applied for several organs. [52] Such SG organoids should ideally represent the cellular heterogeneity (i.e., include duct cells as well as sebocytes) and ensure the presence of sebocytes at various differentiation stages. While the isolation and routine culture of SG stem cells remains elusive, prospective studies could greatly benefit from the use of microfluidic, a standard technique in the area of organ-on-chip, [53] and from the development of advanced scaffolds allowing desirable cellular allocations and interactions. In an initial step, the use of decellularized matrix scaffolds [54] may be suitable to find out suitable experimental conditions.
As a consequence of their present limitations, it cannot be excluded that, for some studies, the advantages of employing an in vivo system will prevail over the drawbacks of studying SG functions in a different species. For example, recent works elucidating important aspects of SG biology, such as the morphogenesis of SGs during development, [55] the mechanism of holocrine secretion [56] or the protective role of sebum, [28] have been performed in vivo using mouse models. The relevance of the latter studies for human diseases, however, remains questionable in the light of the already-mentioned species-specific differences in SG lipogenesis, sebum functions and the contradictory response of animal sebocyte models to drug treatment. [10, 26, 57] These are the most prominent contradictions and challenges future experimental models and studies addressing SG and sebum functions in health and disease will have to cope with.
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